Patent ID: 6184033
Filing Date: 2001-02-06
Classification: A61K

Abstract:
A pharmaceutical composition for administration to a human having acquired immune deficiency syndrome caused by HIV-infection, which comprises:a cell suspension from a single human embryo having a gestation of seven weeks or less wherein said cell suspension is selected from the group consisting of human hematopoietic liver cells, human hematopoietic spleen cells and a mixture of human hematopoietic liver and spleen cells; and in which the contents of nucleated cells is 5 to 200.times.10.sup.6 ; the contents of colony-forming units of granulocyte/macrophage (CFU-GM) is 20 to 200.times.10.sup.3 /ml; the contents of colony-forming units of granulocyte, erythrocyte, monocytelmacrophage, megakaryocyte (CFU-GEMM) is 0.5 to 50.times.10.sup.3 /ml; and the contents of progenitor cells is (CD 34) 1 to 20.times.10.sup.6 /ml.